Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PTEN Phosphohydrolase | 8 | 2021 | 986 | 1.610 |
Why?
|
| Tumor Suppressor Proteins | 13 | 2012 | 1823 | 1.390 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 4 | 2011 | 32 | 0.940 |
Why?
|
| Ubiquitination | 5 | 2021 | 575 | 0.780 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2012 | 216 | 0.690 |
Why?
|
| Mitosis | 4 | 2009 | 615 | 0.630 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 854 | 0.540 |
Why?
|
| Nuclear Proteins | 6 | 2012 | 3343 | 0.430 |
Why?
|
| Cell Cycle Proteins | 6 | 2010 | 2045 | 0.410 |
Why?
|
| Molecular Chaperones | 3 | 2008 | 264 | 0.330 |
Why?
|
| Cellular Senescence | 1 | 2011 | 382 | 0.330 |
Why?
|
| Ubiquitins | 1 | 2008 | 86 | 0.320 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2007 | 51 | 0.310 |
Why?
|
| Cadherins | 1 | 2011 | 660 | 0.310 |
Why?
|
| S Phase | 1 | 2007 | 281 | 0.290 |
Why?
|
| G1 Phase | 1 | 2007 | 285 | 0.290 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 4 | 2011 | 19 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2008 | 1439 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 507 | 0.250 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 589 | 0.250 |
Why?
|
| Spindle Apparatus | 1 | 2004 | 93 | 0.250 |
Why?
|
| Centrosome | 1 | 2004 | 95 | 0.250 |
Why?
|
| Neoplasms | 3 | 2021 | 15193 | 0.230 |
Why?
|
| Cell Nucleus | 4 | 2012 | 1620 | 0.230 |
Why?
|
| Cdc20 Proteins | 4 | 2009 | 25 | 0.210 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 3 | 2012 | 40 | 0.190 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 4053 | 0.190 |
Why?
|
| Heat-Shock Proteins | 1 | 2001 | 311 | 0.180 |
Why?
|
| Protein Kinase C | 1 | 2001 | 396 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 371 | 0.170 |
Why?
|
| Isoenzymes | 1 | 2001 | 614 | 0.170 |
Why?
|
| Co-Repressor Proteins | 2 | 2008 | 122 | 0.160 |
Why?
|
| HeLa Cells | 5 | 2009 | 1643 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2001 | 848 | 0.150 |
Why?
|
| Transcription Factors | 2 | 2008 | 5270 | 0.140 |
Why?
|
| Aurora Kinases | 3 | 2011 | 189 | 0.140 |
Why?
|
| Cell Proliferation | 2 | 2012 | 7226 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2021 | 1026 | 0.130 |
Why?
|
| Cyclins | 2 | 2007 | 456 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 2 | 2013 | 1443 | 0.120 |
Why?
|
| Animals | 12 | 2014 | 59536 | 0.120 |
Why?
|
| Mice | 9 | 2014 | 34495 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2001 | 2022 | 0.110 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 1082 | 0.110 |
Why?
|
| Cell Line, Tumor | 5 | 2012 | 14551 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2008 | 1682 | 0.100 |
Why?
|
| Neoplasm Transplantation | 2 | 2013 | 1519 | 0.100 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2009 | 189 | 0.100 |
Why?
|
| Promyelocytic Leukemia Protein | 2 | 2008 | 55 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 287 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2014 | 11965 | 0.090 |
Why?
|
| Qa-SNARE Proteins | 1 | 2009 | 37 | 0.090 |
Why?
|
| Proto-Oncogenes | 1 | 2010 | 202 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2011 | 243 | 0.090 |
Why?
|
| Cytokinesis | 1 | 2009 | 57 | 0.090 |
Why?
|
| Prometaphase | 1 | 2009 | 2 | 0.090 |
Why?
|
| Protein Binding | 2 | 2007 | 3438 | 0.090 |
Why?
|
| Humans | 20 | 2021 | 261506 | 0.090 |
Why?
|
| Stomach Neoplasms | 1 | 2001 | 2278 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2012 | 1258 | 0.080 |
Why?
|
| Introns | 1 | 2010 | 432 | 0.080 |
Why?
|
| Multigene Family | 1 | 2010 | 425 | 0.080 |
Why?
|
| Cyclin D | 1 | 2007 | 37 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2013 | 2947 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 323 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 973 | 0.080 |
Why?
|
| Phosphorylation | 4 | 2009 | 4804 | 0.080 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 260 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2007 | 198 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2007 | 1064 | 0.070 |
Why?
|
| Tretinoin | 1 | 2008 | 623 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2011 | 1385 | 0.070 |
Why?
|
| Transfection | 2 | 2007 | 2944 | 0.070 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2008 | 430 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2009 | 2216 | 0.060 |
Why?
|
| Prostatic Neoplasms | 3 | 2011 | 5767 | 0.060 |
Why?
|
| Gene Products, pol | 1 | 2003 | 8 | 0.060 |
Why?
|
| Annexin A2 | 1 | 2003 | 15 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 803 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 7789 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 5112 | 0.060 |
Why?
|
| Apoptosis | 2 | 2008 | 7591 | 0.050 |
Why?
|
| S100 Proteins | 1 | 2003 | 181 | 0.050 |
Why?
|
| Microtubules | 1 | 2004 | 270 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 8873 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2006 | 1764 | 0.050 |
Why?
|
| DNA Repair Enzymes | 1 | 2003 | 237 | 0.050 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2001 | 33 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2001 | 80 | 0.050 |
Why?
|
| Cell Survival | 1 | 2007 | 3045 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2359 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2001 | 328 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2001 | 246 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2003 | 545 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 4143 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2007 | 5637 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 4821 | 0.040 |
Why?
|
| Protein Transport | 2 | 2012 | 734 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2004 | 1694 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 1555 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1070 | 0.040 |
Why?
|
| Mutation | 3 | 2014 | 15179 | 0.040 |
Why?
|
| Gene Expression | 1 | 2004 | 3570 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2004 | 4307 | 0.030 |
Why?
|
| Cell Line | 1 | 2004 | 5114 | 0.030 |
Why?
|
| DNA Damage | 1 | 2003 | 1954 | 0.030 |
Why?
|
| Male | 5 | 2014 | 123000 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 3101 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2013 | 56 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2014 | 240 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 6915 | 0.030 |
Why?
|
| Cytosine | 1 | 2013 | 141 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2014 | 602 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2012 | 52 | 0.030 |
Why?
|
| Body Size | 1 | 2012 | 70 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2001 | 6150 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3230 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 508 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 741 | 0.020 |
Why?
|
| Minichromosome Maintenance Complex Component 7 | 1 | 2010 | 14 | 0.020 |
Why?
|
| Aurora Kinase B | 1 | 2009 | 68 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 201 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 15694 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 1408 | 0.020 |
Why?
|
| G2 Phase | 1 | 2009 | 206 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 1489 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 611 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 5319 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 810 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2009 | 11538 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2054 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2012 | 992 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1678 | 0.020 |
Why?
|
| fas Receptor | 1 | 2006 | 185 | 0.020 |
Why?
|
| Mitochondria | 1 | 2012 | 1282 | 0.020 |
Why?
|
| Cell Division | 1 | 2009 | 2489 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 591 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 2488 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 2003 | 54 | 0.010 |
Why?
|
| MRE11 Homologue Protein | 1 | 2003 | 39 | 0.010 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2003 | 84 | 0.010 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2003 | 126 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2003 | 127 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 2003 | 187 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 2450 | 0.010 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2003 | 430 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 652 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 769 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 1265 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 1351 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 1487 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2005 | 1910 | 0.010 |
Why?
|
| ras Proteins | 1 | 2003 | 770 | 0.010 |
Why?
|
| Calcium | 1 | 2003 | 1537 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 5395 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2005 | 2669 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 9180 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 13658 | 0.010 |
Why?
|
| Female | 2 | 2014 | 141928 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 21713 | 0.000 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 10331 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 29902 | 0.000 |
Why?
|
| Aged | 1 | 2005 | 70117 | 0.000 |
Why?
|
| Adult | 1 | 2005 | 77950 | 0.000 |
Why?
|
| Middle Aged | 1 | 2005 | 86204 | 0.000 |
Why?
|